Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-25 @ 5:36 PM
NCT ID:
NCT03342404
Group ID:
EG000
Title:
Luspatercept
Description:
Luspatercept was administered as subcutaneous injection once every 3 weeks (administered on Study Day 1 of each 21-day treatment cycle). The starting dose level was 1.00 mg/kg and could be escalated to 1.25 mg/kg and/or reduced to 0.80, 0.60, and 0.45 mg/kg. Participants were treated for a minimum of 48 weeks.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
96
Other Number Affected:
96
Other Number At Risk:
96
Study:
NCT03342404
Results Section:
NCT03342404
Adverse Events Module:
NCT03342404